Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

Cajal Neuroscience is a drug discovery company built for one purpose: to deliver new medicines that give life back to patients suffering from neurodegenerative disease.

• Industry

  • Biotechnology
  • Health + Tech
  • Neuroscience

• Milestones

  • Lux investment: 2020

• Founders

  • Ian Peikon, PhD
  • Charles Zuker, PhD
  • Huda Zoghbi, MD
  • Tony Zador, MD, PhD
  • Rob Hershberg, MD, PhD
  • Andrew Dervan, MD

  LUX Partners

  • Ian Peikon
  • Adam Goulburn

• Latest Tweets

  • 1 week from today - hear from our own @MollyGasp and @ipeikon at this free career panel hosted by @satijalab! https://t.co/yZElrxcozC@CajalNeuro - 4h
  • Can't wait to expand the ASO drug discovery team at Cajal! https://t.co/eUgM9SBeJq@CajalNeuro - 01:35 AM Sep 1st
  • Come join a fun startup in Seattle working in neuroscience. Looking for a sharp scientist on the rise. https://t.co/R1PmkZWBWr@CajalNeuro - 05:07 AM Oct 27th